Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for Myocardial Inflammation in Systemic Sclerosis
NCT03607071Phase 2Completed
- Sponsor
- Khon Kaen University
- Start
- May 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of prednisolone in myocarditis, sponsored by Khon Kaen University. Primary endpoint: Change in degree of myocarditis at 24 weeks. Started May 2018; status: completed.
02
Drugs
prednisolone
03
Conditions
myocarditis
Beyond the preview
Go deeper on NCT03607071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607071.